Antitumor Activity of the Oral EGFR/HER2 Inhibitor TAK-788 in NSCLC with EGFR Exon 20 Insertions Riely, G., Neal, J., Camidge, D. R., Spira, A., Piotrowska, Z., Horn, L., Costa, D., Tsao, A., Patel, J., Gadgeel, S., Bazhenova, L., Zhu, V., West, H., Vincent, S., Zhu, J., Jin, S., Zhang, S., Li, S., Janne, P. ELSEVIER SCIENCE INC. 2019: S412–S413

View details for Web of Science ID 000492162202171